Acurx Pharmaceuticals, Inc. (ACXP) vs Pulmatrix, Inc. (PULM)
A side-by-side comparison of Acurx Pharmaceuticals, Inc. and Pulmatrix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACXP
Acurx Pharmaceuticals, Inc.
$1.31HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
PULM
Pulmatrix, Inc.
$1.43HealthcareDelayed quote: Oct 6, 2026, 1:45 PM EDT
Total return — ACXP vs PULM
growth of $100 · dividends reinvested · last 5yACXP -99.2% (-61.6%/yr)PULM -92.9% (-41.1%/yr)PULM compounded faster over this window
Log scale — wide-divergence pair
ACXP PULM
ACXP vs PULM: by the numbers
- •ACXP is the larger company ($6M vs $5M market cap).
Metrics side by side
Valuation
| Metric | ACXP | PULM |
|---|---|---|
| P/B ratio | 0.69 | 3.28 |
Profitability
| Metric | ACXP | PULM |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -92.08% | -156.94% |
| ROIC | -94.08% | -160.81% |
Growth (annualized)
| Metric | ACXP | PULM |
|---|---|---|
| Total return CAGR (5Y) | -57.41% | -37.13% |
Frequently asked
- How have ACXP and PULM total returns compared?
- Over the past 5 years, ACXP delivered -57.41% and PULM delivered -37.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.